Accepted for Publication: September 1, 2022.
Published: October 19, 2022. doi:10.1001/jamanetworkopen.2022.37540
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Gustafson MS et al. JAMA Network Open.
Corresponding Author: Holly Fernandez Lynch, JD, MBE, University of Pennsylvania Perelman School of Medicine, 423 Guardian Dr, 1426 Blockley Hall, Philadelphia, PA 19104 (email@example.com).
Author Contributions: Ms Gustafson had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Gustafson, Fernandez Lynch.
Acquisition, analysis, or interpretation of data: Gustafson, Patel, Hong, Meline, Pena, Tang.
Drafting of the manuscript: Gustafson, Patel.
Critical revision of the manuscript for important intellectual content: Gustafson, Hong, Meline, Pena, Tang, Fernandez Lynch.
Statistical analysis: Patel, Hong, Meline.
Administrative, technical, or material support: Gustafson, Patel, Pena, Tang, Fernandez Lynch.
Supervision: Gustafson, Fernandez Lynch.
Conflict of Interest Disclosures: Ms Gustafson reported serving as an affiliate of the NYU Grossman School of Medicine Compassionate Use and Preapproval Access Working Group (CUPA) during the conduct of the study. Mr Meline and Ms Pena reported receiving funding through the Leonard Davis Institute at the University of Pennsylvania. Dr Fernandez Lynch reported receiving grants from The Greenwall Foundation and the NIH during the conduct of the study; personal fees from The Robert Wood Johnson Foundation outside the submitted work; and serving as a member of the NYU Grossman School of Medicine CUPA. No other disclosures were reported.
Additional Contributions: We thank John Holmes, PhD, Institute for Biomedical Informatics, Perelman School of Medicine, University of Pennsylvania, for guidance regarding study methodology and reporting, and Kyle Cunningham-Rhoads, BA, Stats Perform, for input regarding data analysis. No compensation was provided for this assistance.
OSF Project Files. Gustafson MS, Lynch HF, Tang C, Patel A, Pena D, Meline M. Characteristics of trials at sites participating in the COVID-19 Convalescent Plasma Expanded Access Program. April 11, 2022. Accessed September 10, 2022. https://osf.io/n4xgd/